Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Herold-Mende, Christel"" wg kryterium: Autor


Tytuł:
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
Autorzy:
Hai, LingAff1, Aff2, Aff3, Aff4
Hoffmann, Dirk C.Aff2, Aff3, Aff4
Wagener, Robin J.Aff2, Aff3
Azorin, Daniel D.
Hausmann, DavidAff2, Aff3
Xie, Ruifan
Huppertz, Magnus-Carsten
Hiblot, Julien
Sievers, PhilippAff6, Aff7
Heuer, SophieAff2, Aff3
Ito, Jakob
Cebulla, Gina
Kourtesakis, AlexandrosAff2, Aff3, Aff4
Kaulen, Leon D.Aff2, Aff3
Ratliff, MiriamAff2, Aff8
Mandelbaum, Henriette
Jung, ErikAff2, Aff3
Jabali, AmmarAff9, Aff10, Aff11, Aff12
Horschitz, SandraAff9, Aff10, Aff11
Ernst, Kati J.Aff13, Aff14
Reibold, Denise
Warnken, Uwe
Venkataramani, VarunAff2, Aff3, Aff15
Will, Rainer
Suvà, Mario L.Aff17, Aff18
Herold-Mende, Christel
Sahm, FelixAff6, Aff7
Winkler, FrankAff2, Aff3
Schlesner, MatthiasAff1, Aff20
Wick, WolfgangAff2, Aff3
Kessler, TobiasAff2, Aff3, IDs41467024450678_cor31
Pokaż więcej
Źródło:
Nature Communications. 15(1)
Czasopismo naukowe
Tytuł:
The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence.
Autorzy:
Barbosa S; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Department of Morphological Sciences, Institute of Basic Health Science, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-003, RS, Brazil.
Laureano NK; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Department of Oral Pathology, Faculty of Dental Sciences, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-004, RS, Brazil.
Hadiwikarta WW; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.
Visioli F; Department of Oral Pathology, Faculty of Dental Sciences, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-004, RS, Brazil.
Bonrouhi M; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pajdzik K; Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Conde-Lopez C; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Herold-Mende C; Department of Neurosurgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Eidt G; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Langie R; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Oral Pathology, Faculty of Dental Sciences, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-004, RS, Brazil.
Lamers ML; Department of Morphological Sciences, Institute of Basic Health Science, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-003, RS, Brazil.
Stögbauer F; Tissue Bank of the National Center for Tumor Diseases (NCT) Heidelberg, Germany and Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Institute of Pathology, School of Medicine, Technical University of Munich (TUM), 80337 Munich, Germany.
Hess J; Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Kurth I; Division of Radiooncology/Radiobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
Jou A; Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Dentistry, Institute of Toxicology and Pharmacology, Pontifícial Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre 90619-900, RS, Brazil.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Jan 19; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma
Autorzy:
Martija, Antoni AndreuAff1, Aff2, Aff3
Krauß, AlexandraAff1, Aff2, Aff4
Bächle, NatalieAff1, Aff2, Aff3, Aff5
Doth, LauraAff1, Aff2, Aff3
Christians, ArneAff6, Aff7
Krunic, Damir
Schneider, Martin
Helm, Dominic
Will, Rainer
Hartmann, Christian
Herold-Mende, Christel
von Deimling, AndreasAff1, Aff2
Pusch, StefanAff1, Aff2, IDs4047802301673z_cor13
Pokaż więcej
Źródło:
Acta Neuropathologica Communications. 11(1)
Czasopismo naukowe
Tytuł:
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
Autorzy:
Rahmanzade, RaminAff1, Aff2
Pfaff, ElkeAff3, Aff4, Aff5
Banan, RouzbehAff1, Aff2
Sievers, PhilippAff1, Aff2
Suwala, Abigail K.Aff1, Aff2
Hinz, FelixAff1, Aff2
Bogumil, HenriAff1, Aff2
Cherkezov, AsanAff1, Aff2
Kaan, Aras FuatAff1, Aff2
Schrimpf, DanielAff1, Aff2
Friedel, DennisAff1, Aff2
Göbel, KirstenAff1, Aff2
Keller, FelixAff1, Aff2
Saenz-Sardà, Xavier
Lossos, Alexander
Sill, MartinAff3, Aff4
Witt, OlafAff3, Aff4, Aff11
Sakowitz, Oliver W.
Korshunov, AndreyAff1, Aff2, Aff3
Reuss, David E.Aff1, Aff2
Etminan, Nima
Unterberg, Andreas
Ratliff, MiriamAff7, Aff8
Herold-Mende, Christel
Wick, WolfgangAff14, Aff15
Pfister, Stefan M.Aff3, Aff4
von Deimling, AndreasAff1, Aff2
Jones, David T. W.Aff3, Aff5
Sahm, FelixAff3, Aff16, Aff17, IDs00401023026381_cor29
Pokaż więcej
Źródło:
Acta Neuropathologica: Pathology and Mechanisms of Neurological Disease. 146(6):853-856
Czasopismo naukowe
Tytuł:
scSNPdemux: a sensitive demultiplexing pipeline using single nucleotide polymorphisms for improved pooled single-cell RNA sequencing analysis
Autorzy:
Wong, John K. L.Aff1, IDs12859023054408_cor1
Jassowicz, LenaAff1, Aff2
Herold-Mende, Christel
Seiffert, Martina
Mallm, Jan-Philipp
Lichter, Peter
Zapatka, MarcAff1, IDs12859023054408_cor7
Pokaż więcej
Źródło:
BMC Bioinformatics. 24(1)
Czasopismo naukowe
Tytuł:
Concurrent gliomas in patients with multiple sclerosis
Autorzy:
Sahm, KatharinaAff1, Aff2, IDs4385602300381y_cor1
Kessler, TobiasAff3, Aff4
Eisele, Philipp
Ratliff, Miriam
Sperk, Elena
König, Laila
Breckwoldt, Michael O.Aff2, Aff8
Seliger, CorinnaAff4, Aff9
Mildenberger, IrisAff1, Aff2
Schrimpf, DanielAff10, Aff11
Herold-Mende, Christel
Zeiner, Pia S.
Tabatabai, Ghazaleh
Meuth, Sven G.
Capper, DavidAff16, Aff17
Bendszus, Martin
von Deimling, AndreasAff10, Aff11
Wick, WolfgangAff3, Aff4
Sahm, FelixAff10, Aff11
Platten, MichaelAff1, Aff2, IDs4385602300381y_cor20
Pokaż więcej
Źródło:
Communications Medicine. 3(1)
Czasopismo naukowe
Tytuł:
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
Autorzy:
Selt, Florian
El Damaty, Ahmed
Schuhmann, Martin U.
Sigaud, Romain
Ecker, Jonas
Sievers, Philipp
Kocher, Daniela
Herold-Mende, Christel
Oehme, Ina
von Deimling, Andreas
Pfister, Stefan M.
Sahm, Felix
Jones, David T. W.
Witt, Olaf
Milde, Till
Pokaż więcej
Źródło:
Journal of Neuro-Oncology; Dec2023, Vol. 165 Issue 3, p467-478, 12p
Czasopismo naukowe
Tytuł:
Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells.
Autorzy:
Rehbein, Sarah (AUTHOR)
Possmayer, Anna-Lena (AUTHOR)
Bozkurt, Süleyman (AUTHOR)
Lotsch, Catharina (AUTHOR) christel.herold-mende@med.uni-heidelberg.de
Gerstmeier, Julia (AUTHOR)
Burger, Michael (AUTHOR)
Momma, Stefan (AUTHOR)
Maletzki, Claudia (AUTHOR)
Classen, Carl Friedrich (AUTHOR)
Freiman, Thomas M. (AUTHOR)
Dubinski, Daniel (AUTHOR)
Lamszus, Katrin (AUTHOR)
Stringer, Brett W. (AUTHOR)
Herold-Mende, Christel (AUTHOR)
Münch, Christian (AUTHOR)
Kögel, Donat (AUTHOR)
Linder, Benedikt (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Nov2023, Vol. 15 Issue 21, p5249. 22p.
Czasopismo naukowe
Tytuł:
Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high‐grade gliomas.
Autorzy:
Reuss, David E. (AUTHOR)
Downing, Susanna M. (AUTHOR)
Camacho, Cristel V. (AUTHOR)
Wang, Yong‐Dong (AUTHOR)
Piro, Rosario M. (AUTHOR)
HeroldMende, Christel (AUTHOR)
Wang, Zhao‐Qi (AUTHOR)
Hofmann, Thomas G. (AUTHOR)
Sahm, Felix (AUTHOR)
von Deimling, Andreas (AUTHOR)
McKinnon, Peter J. (AUTHOR)
Frappart, Pierre‐Olivier (AUTHOR)
Pokaż więcej
Źródło:
Neuropathology & Applied Neurobiology. Aug2023, Vol. 49 Issue 4, p1-15. 15p.
Czasopismo naukowe
Tytuł:
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
Autorzy:
Bogumil, HenriAff1, Aff2
Sill, MartinAff3, Aff4
Schrimpf, DanielAff1, Aff2
Ismer, BrittaAff3, Aff5, Aff6
Blume, ChristinaAff1, Aff2
Rahmanzade, RaminAff1, Aff2
Hinz, FelixAff1, Aff2
Cherkezov, AsanAff1, Aff2
Banan, RouzbehAff1, Aff2
Friedel, DennisAff1, Aff2
Reuss, David E.Aff1, Aff2
Selt, FlorianAff3, Aff7, Aff8, Aff9
Ecker, JonasAff3, Aff7, Aff8, Aff9
Milde, TillAff3, Aff7, Aff8, Aff9
Pajtler, Kristian W.Aff3, Aff4, Aff8
Schittenhelm, JensAff10, Aff11, Aff12
Hench, Jürgen
Frank, Stephan
Boldt, Henning B.Aff14, Aff15
Kristensen, Bjarne WintherAff14, Aff15, Aff16, Aff17
Scheie, David
Melchior, Linea C.
Olesen, Viola
Sehested, Astrid
Boué, Daniel R.
Abdullaev, Zied
Satgunaseelan, Laveniya
Kurth, Ina
Seidlitz, AnnekatrinAff9, Aff25, Aff26, Aff27, Aff28, Aff29, Aff30, Aff31
White, Christine L.Aff32, Aff33, Aff34
Ng, Ho-KeungAff35, Aff36
Shi, Zhi-FengAff36, Aff37
Haberler, Christine
Deckert, Martina
Timmer, Marco
Goldbrunner, Roland
Tauziède-Espariat, ArnaultAff41, Aff42
Varlet, PascaleAff41, Aff42
Brandner, SebastianAff43, Aff44
Alexandrescu, Sanda
Snuderl, Matija
Aldape, Kenneth
Korshunov, AndreyAff1, Aff2, Aff3
Witt, OlafAff3, Aff7, Aff8, Aff9
Herold-Mende, Christel
Unterberg, Andreas
Wick, WolfgangAff49, Aff50
Pfister, Stefan M.Aff3, Aff4, Aff8, Aff9
von Deimling, AndreasAff1, Aff2
Jones, David T. W.Aff3, Aff5
Sahm, FelixAff1, Aff2, Aff3, Aff9
Sievers, PhilippAff1, Aff2, IDs00401023025580_cor52
Pokaż więcej
Źródło:
Acta Neuropathologica: Pathology and Mechanisms of Neurological Disease. 145(5):667-680
Czasopismo naukowe
Tytuł:
Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical Score.
Autorzy:
Dao Trong, Philip (AUTHOR)
Kilian, Samuel (AUTHOR)
Jesser, Jessica (AUTHOR)
Reuss, David (AUTHOR)
Aras, Fuat Kaan (AUTHOR)
Von Deimling, Andreas (AUTHOR)
Herold-Mende, Christel (AUTHOR)
Unterberg, Andreas (AUTHOR)
Jungk, Christine (AUTHOR)
Pokaż więcej
Źródło:
Cancers. May2023, Vol. 15 Issue 9, p2503. 14p.
Czasopismo naukowe
Tytuł:
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells.
Autorzy:
Dao Trong P; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, INF400, 69120 Heidelberg, Germany.
Jungwirth G; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, INF400, 69120 Heidelberg, Germany.
Unterberg A; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, INF400, 69120 Heidelberg, Germany.
Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, INF400, 69120 Heidelberg, Germany.
Warta R; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, INF400, 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Apr 20; Vol. 12 (8). Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Neoplasms*/pathology
Glioma*/drug therapy
Glioma*/genetics
Glioma*/pathology
Humans ; Anticonvulsants/pharmacology ; Oxcarbazepine/pharmacology ; Isocitrate Dehydrogenase/genetics
Czasopismo naukowe
Tytuł:
MR-Class: A Python Tool for Brain MR Image Classification Utilizing One-vs-All DCNNs to Deal with the Open-Set Recognition Problem.
Autorzy:
Salome P; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, 69120 Heidelberg, Germany.; Heidelberg Medical Faculty, Heidelberg University, 69117 Heidelberg, Germany.; German Cancer Consortium Core Center Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, 69120 Heidelberg, Germany.
Sforazzini F; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, 69120 Heidelberg, Germany.; Heidelberg Medical Faculty, Heidelberg University, 69117 Heidelberg, Germany.; German Cancer Consortium Core Center Heidelberg, 69120 Heidelberg, Germany.
Grugnara G; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Kudak A; Heidelberg Ion-Beam Therapy Center, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Therapy, German Cancer Research Center, 69120 Heidelberg, Germany.
Dostal M; Heidelberg Ion-Beam Therapy Center, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Therapy, German Cancer Research Center, 69120 Heidelberg, Germany.
Herold-Mende C; Brain Tumour Group, European Organization for Research and Treatment of Cancer, 1200 Brussels, Belgium.; Division of Neurosurgical Research, Department of Neurosurgery, University of Heidelberg, 69117 Heidelberg, Germany.
Heiland S; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Debus J; German Cancer Consortium Core Center Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Abdollahi A; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, 69120 Heidelberg, Germany.; German Cancer Consortium Core Center Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Knoll M; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, 69120 Heidelberg, Germany.; German Cancer Consortium Core Center Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Mar 17; Vol. 15 (6). Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
MR Intensity Normalization Methods Impact Sequence Specific Radiomics Prognostic Model Performance in Primary and Recurrent High-Grade Glioma.
Autorzy:
Salome P; Clinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.; Heidelberg Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK) Core Centre Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.
Sforazzini F; Clinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.; Heidelberg Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK) Core Centre Heidelberg, 69120 Heidelberg, Germany.
Grugnara G; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Kudak A; Heidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany.; CCU Radiation Therapy, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.
Dostal M; Heidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany.; CCU Radiation Therapy, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.
Herold-Mende C; Brain Tumour Group, European Organization for Research and Treatment of Cancer, 1200 Brussels, Belgium.; Division of Neurosurgical Research, Department of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Heiland S; Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Debus J; German Cancer Consortium (DKTK) Core Centre Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany.
Abdollahi A; Clinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK) Core Centre Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany.
Knoll M; Clinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK) Core Centre Heidelberg, 69120 Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Feb 02; Vol. 15 (3). Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies